Black Diamond Therapeutics (BDTX) Prepaid Assets (2018 - 2026)
Black Diamond Therapeutics (BDTX) posted Prepaid Assets of $4.7 million for Q1 2026, up 24.31% on a QoQ basis from $3.8 million in Q4 2025, and up 43.61% year-over-year from $3.3 million in Q1 2025.
Black Diamond Therapeutics (BDTX) Prepaid Assets (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics' Prepaid Assets history runs 9 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- Quarterly Prepaid Assets rose 43.61% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 43.61% YoY) and the FY2025 annual result came in at $3.8 million, up 45.64% from the prior year.
- Prepaid Assets was $4.7 million for Q1 2026 at Black Diamond Therapeutics, up from $3.8 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $8.6 million in Q1 2022 and bottomed at $2.6 million in Q4 2024.
- A 5-year average of $4.3 million and a median of $3.8 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets sank 58.91% — and 2025, when it surged 45.64%.
- Black Diamond Therapeutics' Prepaid Assets stood at $4.9 million in 2022, then sank by 46.23% to $2.6 million in 2023, then slipped by 1.25% to $2.6 million in 2024, then jumped by 45.64% to $3.8 million in 2025, then increased by 24.31% to $4.7 million in 2026.
- Business Quant data shows BDTX's Prepaid Assets at $4.7 million in Q1 2026, $3.8 million in Q4 2025, and $3.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Black Diamond Therapeutics | 99.59 Mn | -18.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.71 Mn |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | 3.49 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 3.61 Mn |
| Dec 31, 2023 | 2.63 Mn |
| Sep 30, 2023 | 2.79 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 4.61 Mn |
| Dec 31, 2022 | 4.90 Mn |
| Sep 30, 2022 | 6.80 Mn |
| Jun 30, 2022 | 7.67 Mn |
| Mar 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Sep 30, 2021 | 6.54 Mn |
| Jun 30, 2021 | 7.48 Mn |